Pandion Therapeutics, Inc. - FORM S-1 - EX-23.1 - June 26, 2020

Attached files

file filename
EX-21.1 - EX-21.1 - Pandion Therapeutics, Inc.d926475dex211.htm
EX-10.20 - EX-10.20 - Pandion Therapeutics, Inc.d926475dex1020.htm
EX-10.19 - EX-10.19 - Pandion Therapeutics, Inc.d926475dex1019.htm
EX-10.18 - EX-10.18 - Pandion Therapeutics, Inc.d926475dex1018.htm
EX-10.17 - EX-10.17 - Pandion Therapeutics, Inc.d926475dex1017.htm
EX-10.16 - EX-10.16 - Pandion Therapeutics, Inc.d926475dex1016.htm
EX-10.15 - EX-10.15 - Pandion Therapeutics, Inc.d926475dex1015.htm
EX-10.14 - EX-10.14 - Pandion Therapeutics, Inc.d926475dex1014.htm
EX-10.13 - EX-10.13 - Pandion Therapeutics, Inc.d926475dex1013.htm
EX-10.12 - EX-10.12 - Pandion Therapeutics, Inc.d926475dex1012.htm
EX-10.11 - EX-10.11 - Pandion Therapeutics, Inc.d926475dex1011.htm
EX-10.10 - EX-10.10 - Pandion Therapeutics, Inc.d926475dex1010.htm
EX-10.9 - EX-10.9 - Pandion Therapeutics, Inc.d926475dex109.htm
EX-10.8 - EX-10.8 - Pandion Therapeutics, Inc.d926475dex108.htm
EX-10.7 - EX-10.7 - Pandion Therapeutics, Inc.d926475dex107.htm
EX-10.1 - EX-10.1 - Pandion Therapeutics, Inc.d926475dex101.htm
EX-4.1 - EX-4.1 - Pandion Therapeutics, Inc.d926475dex41.htm
EX-3.5 - EX-3.5 - Pandion Therapeutics, Inc.d926475dex35.htm
EX-3.4 - EX-3.4 - Pandion Therapeutics, Inc.d926475dex34.htm
EX-3.1 - EX-3.1 - Pandion Therapeutics, Inc.d926475dex31.htm
S-1 - S-1 - Pandion Therapeutics, Inc.d926475ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated May 22, 2020, relating to the financial statements of Pandion Therapeutics Holdco LLC. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

June 26, 2020